About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ACOR - Acorda Therapeutics| Previous Close | $3.75 | Open | $3.80 |
| Volume | 555K | Market Cap | 35.56M |
| Yield | Last Dividend |
| Heres What to Focus on: Ideanomics, Inc.... | 08/03/21 |
| Ideanomics, Inc. (IDEX) with the stream of -1.26% also noticed, India Acorda Therapeutics, Inc. (ACOR) encountered a rapid change of 4.57% in the last... | |
| Glowing Stocks Review: NovaBay Pharmaceu... | 07/30/21 |
| NovaBay Pharmaceuticals, Inc. (AMEX:NBY) with the stream of 2.84% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid chan... | |
| Acorda Second Quarter 2021 Update: Webca... | 07/30/21 |
| No summary available. | |
| Astounding Stock: Acorda Therapeutics, I... | 07/26/21 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) with the stream of -6.34% also noticed, India Cenovus Energy Inc. (NYSE:CVE) encountered a rapid change of 1.4... | |
| Important Technical Indicators to watch:... | 07/25/21 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) with the stream of 24.15% also noticed, India Skillz Inc. (NYSE:SKLZ) encountered a rapid change of 4.44% in t... | |
| Acorda Therapeutics (ACOR.Q) Taking Pill... | 07/23/21 |
| Acorda Therapeutics (ACOR.Q) announced today that it has entered into a distribution and supply agreement with Esteve Pharmaceuticals to commercialize... | |
| Thinking about buying stock in Acorda Th... | 07/23/21 |
| NEW YORK, July 23, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACOR, OCUL, OCGN, ARPO, and AVXL. To see how Investors... | |
| The Daily Biotech Pulse: Acorda Spikes O... | 07/23/21 |
| Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bi... | |
| Acorda Therapeutics Shares Gains On Spai... | 07/23/21 |
| Acorda Therapeutics Inc (NASDAQ: ACOR ) has entered into distribution and supply agreements with Esteve Pharmaceuticals S.A. to commercialize Inbrija ... | |
| Tizanidine HCl Market 2021 SWOT Analysis... | 07/22/21 |
| This report studies the Tizanidine HCl Market with many aspects of the industry such as market size, market status, market trends and forecast. The re... | |
| Acorda shares surge 27% on INBRIJA distr... | 07/22/21 |
| No summary available. | |
| Tizanidine HCl Market is Projected to Sh... | 07/16/21 |
| It shows how the COVID-19 health problem has affected a variety of companies. The COVID-19 epidemic and related lockdown countermeasures have wreaked ... | |
| Flashy Stock: AT&T Inc. (NYSE:T), Acorda... | 07/11/21 |
| AT&T Inc. (NYSE:T) with the stream of 0.96% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid change of -3.44% in the la... | |
| Multiple Sclerosis Drugs Market 2021 Gro... | 07/09/21 |
| Multiple Sclerosis Drugs Market Report provides detailed analysis of Growth Factors of the market as well as it gives an analysis of the Market size, ... | |
| Latest Business Intelligence Solution Fo... | 07/07/21 |
| Up Market Research (UMR) published a latest research report on Diclofenac Patches Sales Market 2021. The Research Report is a comprehensive and in-dep... | |
| Most Recent Figure Make This Stock Even ... | 07/04/21 |
| JD.com, Inc. (NASDAQ:JD) with the stream of -1.56% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid change of -2.38% in... | |
| Bright Trending Stock: Devon Energy Corp... | 06/29/21 |
| Devon Energy Corporation (NYSE:DVN) with the stream of 0.90% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid change of... | |
| Insights on the Spinal Cord Trauma Treat... | 06/21/21 |
| Dublin, June 21, 2021 (GLOBE NEWSWIRE) -- The "Spinal Cord Trauma Treatment - Global Market Trajectory & Analytics" report has been added to ResearchA... | |
| Hedge Funds Are Buying Acorda Therapeuti... | 06/18/21 |
| No summary available. | |
| CureVac downgraded following COVID vacci... | 06/17/21 |
| No summary available. | |
| Analysts Recommendations to Consider: Ci... | 06/16/21 |
| Cinedigm Corp. (NASDAQ:CIDM) with the stream of 2.04% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid change of -1.91%... | |
| Acorda Therapeutics to repay convertible... | 06/16/21 |
| No summary available. | |
| Stock on the Run: Acorda Therapeutics, I... | 06/14/21 |
| Acorda Therapeutics, Inc. (NASDAQ:ACOR) with the stream of 9.35% also noticed, India Vista Gold Corp. (AMEX:VGZ) encountered a rapid change of 13.87% ... | |
| Comprehensive Stock Analysis: Intel Corp... | 06/13/21 |
| Intel Corporation (NASDAQ:INTC) with the stream of 0.82% also noticed, India Acorda Therapeutics, Inc. (NASDAQ:ACOR) encountered a rapid change of 1.3... | |
| Tizanidine HCl Market Demand Will Increa... | 06/03/21 |
| The report focuses on global major leading Industry players of Tizanidine HCl Market providing information such as company profiles, product picture a... | |
| Wall Street acorda a subir ligeiramente | 06/02/21 |
| https://pt.investing.com/news/stock-market-news/wall-street-acorda-a-subir-ligeiramente-776917 | |
| Date | 04/12/2019 (AMC) | Est. (EPS/Rev.) | $1.37 |
| Actual (EPS/Rev.) | $2.5B | EPS (TTM) | $??? |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| LavaPit | Steve Pitkin | 57.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
